hydromorphone hydrochloride

Generic: hydromorphone hydrochloride

Labeler: specgx llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydromorphone hydrochloride
Generic Name hydromorphone hydrochloride
Labeler specgx llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydromorphone hydrochloride 8 mg/1

Manufacturer
SpecGx LLC

Identifiers & Regulatory

Product NDC 0406-3249
Product ID 0406-3249_8c16f6cf-c3d2-458c-9cd1-4fddd7c473a8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076855
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2004-12-23

Pharmacologic Class

Classes
full opioid agonists [moa] opioid agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04063249
Hyphenated Format 0406-3249

Supplemental Identifiers

RxCUI
897696 897702 897710
UPC
0031100000010
UNII
L960UP2KRW

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydromorphone hydrochloride (source: ndc)
Generic Name hydromorphone hydrochloride (source: ndc)
Application Number ANDA076855 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (0406-3249-01)
source: ndc

Packages (1)

Ingredients (1)

hydromorphone hydrochloride (8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8c16f6cf-c3d2-458c-9cd1-4fddd7c473a8", "openfda": {"upc": ["0031100000010"], "unii": ["L960UP2KRW"], "rxcui": ["897696", "897702", "897710"], "spl_set_id": ["4c5c1cc8-c42b-46e3-ad68-8e22f57101f2"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0406-3249-01)", "package_ndc": "0406-3249-01", "marketing_start_date": "20041223"}], "brand_name": "Hydromorphone Hydrochloride", "product_id": "0406-3249_8c16f6cf-c3d2-458c-9cd1-4fddd7c473a8", "dosage_form": "TABLET", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "0406-3249", "dea_schedule": "CII", "generic_name": "hydromorphone hydrochloride", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydromorphone Hydrochloride", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA076855", "marketing_category": "ANDA", "marketing_start_date": "20041223", "listing_expiration_date": "20261231"}